We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Diagnostics

Image: MammaPrint is a 70‑gene expression test that stratifies risk of distant metastasis into UltraLow, Low, High 1, and High 2 categories (photo courtesy of Agendia)

Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers

Two genomic subtyping assays identify aggressive HR+/HER2– tumors driving racial survival disparities. More...
08 Apr 2026
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

Simple Blood Test Enables Multi-Disease Detection from Single Sample

A new cfDNA methylation assay screens for multiple cancers and organ diseases from one blood draw with tissue-of-origin mapping. More...
07 Apr 2026
Image: FINDER is the first molecular point-of-care platform with both FDA 510(k) clearance and CLIA waiver that combines molecular testing with chemistry, coagulation, and immunoassay capabilities on a single multifunctional system (photo courtesy of Baebies)

Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes

Baebies has received FDA 510(k) clearance and CLIA waiver for the FINDER Flu A&B/SARS-CoV-2 Test. More...
07 Apr 2026
Image: Monitoring ctDNA is a powerful tool to assess the absence or presence of MRD (Photo courtesy of Natera)

ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery

A circulating tumor DNA-based molecular residual disease test identifies older ER+/HER2- breast cancer patients who may forgo surgery. More...
06 Apr 2026
Image: Caris Detect uses AI models to analyze peripheral blood for subtle signals of early-stage cancer (photo credit: Adobe Stock)

WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity

A new WGS-based multi-cancer blood test shows stage-stratified sensitivity with high specificity. More...
06 Apr 2026
image: HPV DNA (ctDNA) measured in blood could help tailor treatment for HPV-related throat cancer (photo credit: Adobe Stock)

Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer

New data show circulating tumor HPV DNA, read with pathology, improves risk stratification to tailor therapy in throat cancer. More...
03 Apr 2026
Image: New findings show that transcriptome-enabled profiling can help identify therapeutic opportunities for patients who previously had no actionable results from DNA-only testing (photo courtesy of Shutterstock)

RNA Profiling Uncovers Therapeutic Targets in Solid Tumors

AI-driven RNA profiling reveals therapeutic targets missed by DNA testing in advanced solid tumors. More...
02 Apr 2026
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.